Stem Cells

HighQC™ Human Liver Cancer Stem Cell

  • For research use only

Cat No.

ABC-SC0087

Product Type

Human Cancer Stem Cells

Cell Type

Stem Cell

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

Liver

Disease

Liver Cancer

Storage

Liquid Nitrogen

Human Liver Cancer Stem Cell; Frozen Vial and Plated cells are available.

Product Image

Description

HighQC™ Human Liver Cancer Stem Cells are derived from hepatocellular carcinoma (HCC) specimens and cultured under defined, serum-free, stem cell-selective conditions to enrich tumor-initiating subpopulations. HighQC™ Human Liver Cancer Stem Cells exhibit both epithelial-like and mesenchymal-like morphologies, reflecting the plasticity and heterogeneity typical of LCSCs. They express liver CSC-associated markers including CD 44, CD133, SSEA3/4, Oct4. They demonstrate hallmark properties of cancer stem cells, including enhanced self-renewal, tumorigenicity, and resistance to chemotherapeutic agents. Functionally, they contribute to tumor heterogeneity and recurrence, playing a pivotal role in HCC progression and treatment failure. These liver CSCs provide a robust platform for modeling hepatocarcinogenesis, drug screening, and evaluating immunotherapeutic responses. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.

Product Code

HighQC™ Human Liver Cancer Stem Cell, Human HCC CSC, hHCC-CSC, Human Hepatocellular CSC

Species

Human

Cat.No

ABC-SC0087

Product Category

Stem Cells

Size/Quantity

1 vial

Cell Type

Stem Cell

Growth Mode

Adherent

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Liver

Disease

Liver Cancer

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Human Cancer Stem Cells

Application

  • HighQC™ Human Liver Cancer Stem Cells serve as a valuable tool for studying hepatocellular carcinoma pathogenesis, chemoresistance, and metastasis. Researchers use these cells to develop CSC-targeted therapies, investigate signaling pathways such as Wnt/β-catenin and TGF-β, and create patient-representative xenograft models. These CSCs also support exploration of liver tumor heterogeneity, relapse mechanisms, and immunotherapeutic responses in HCC.

Citation

When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring HighQC™ Human Liver Cancer Stem Cell

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button